Eli Lilly and (LLY) Interest Coverage Ratio: History & Chart

Eli Lilly and Company (LLY)LLYEli Lilly and Company

About Eli Lilly and Company

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer. For autoimmune and inflammatory conditions, the company markets Olumiant for rheumatoid arthritis, and Taltz, which addresses plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Addressing neurological and pain management needs, Eli Lilly provides Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is available for migraine prevention and episodic cluster headaches, while Zyprexa treats schizophrenia, bipolar I disorder, and aids in bipolar maintenance. Other significant products include Bamlanivimab and etesevimab, along with Bebtelovimab, both developed for COVID-19. Cialis is offered for erectile dysfunction and benign prostatic hyperplasia, and Forteo is available for osteoporosis. Eli Lilly actively engages in strategic collaborations with numerous partners, including Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Established in 1876, Eli Lilly and Company maintains its corporate headquarters in Indianapolis, Indiana.

Indianapolis, IN

50,000 employees

www.lilly.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: David A. Ricks

View full financials

LLY Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

26.66x

INTEREST COVERAGE RATIO AVG TTM

39.10x

INTEREST COVERAGE RATIO AVG 3Y

23.07x

INTEREST COVERAGE RATIO AVG 5Y

23.75x

INTEREST COVERAGE RATIO AVG 10Y

21.75x

INTEREST COVERAGE RATIO AVG 15Y

22.95x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-31.83%

CURRENT VS 3Y AVG

+15.52%

CURRENT VS 5Y AVG

+12.24%

CURRENT VS 10Y AVG

+22.57%

CURRENT VS 15Y AVG

+16.15%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

6.77x

median of 73 covered companies

CURRENT VS SECTOR MEDIAN

+293.75%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Eli Lilly and Company (LLY)	$1.08T	26.66x	39.10x	23.07x	23.75x
Johnson & Johnson (JNJ)vs ›	$617.78B	26.36x	27.85x	40.54x	62.46x
AbbVie Inc. (ABBV)vs ›	$443.24B	6.94x	5.10x	6.01x	6.01x
UnitedHealth Group Incorporated (UNH)vs ›	$376.34B	4.74x	6.50x	9.14x	10.75x
Merck & Co., Inc. (MRK)vs ›	$321.62B	17.31x	16.61x	13.70x	12.98x
Thermo Fisher Scientific Inc. (TMO)vs ›	$213.42B	5.71x	5.17x	6.77x	10.10x
Novo Nordisk A/S (NVO)vs ›	$209.19B	30.34x	54.30x	123.94x	139.58x
Amgen Inc. (AMGN)vs ›	$207.87B	3.88x	3.09x	3.93x	4.89x
Abbott Laboratories (ABT)vs ›	$184.11B	23.60x	17.46x	17.67x	16.77x
Gilead Sciences, Inc. (GILD)vs ›	$161.66B	11.43x	6.56x	7.26x	7.18x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Eli Lilly and Company (LLY)

$1.08T

26.66x

39.10x

23.07x

23.75x

Johnson & Johnson (JNJ)vs ›

$617.78B

26.36x

27.85x

40.54x

62.46x

AbbVie Inc. (ABBV)vs ›

$443.24B

6.94x

5.10x

6.01x

UnitedHealth Group Incorporated (UNH)vs ›

$376.34B

4.74x

6.50x

9.14x

10.75x

Merck & Co., Inc. (MRK)vs ›

$321.62B

17.31x

16.61x

13.70x

12.98x

Thermo Fisher Scientific Inc. (TMO)vs ›

$213.42B

5.71x

5.17x

6.77x

10.10x

Novo Nordisk A/S (NVO)vs ›

$209.19B

30.34x

54.30x

123.94x

139.58x

Amgen Inc. (AMGN)vs ›

$207.87B

3.88x

3.09x

3.93x

4.89x

Abbott Laboratories (ABT)vs ›

$184.11B

23.60x

17.46x

17.67x

16.77x

Gilead Sciences, Inc. (GILD)vs ›

$161.66B

11.43x

6.56x

7.26x

7.18x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Eli Lilly and Company (LLY)?

The interest coverage ratio for LLY stock is 26.66x.

Is Eli Lilly and Company's interest coverage ratio high or low?

The interest coverage ratio of 26.66x is in line with its 5-year average of 27.11x, near the low end of its 5-year range (15.23x–71.34x).

What is the TTM average interest coverage ratio for Eli Lilly and Company (LLY)?

The TTM average interest coverage ratio for LLY stock is 39.10x.

What is the 3Y average interest coverage ratio for Eli Lilly and Company (LLY)?

The 3Y average interest coverage ratio for LLY stock is 23.07x.

What is the 5Y average interest coverage ratio for Eli Lilly and Company (LLY)?

The 5Y average interest coverage ratio for LLY stock is 23.75x.

What is the 10Y average interest coverage ratio for Eli Lilly and Company (LLY)?

The 10Y average interest coverage ratio for LLY stock is 21.75x.

What is the 15Y average interest coverage ratio for Eli Lilly and Company (LLY)?

The 15Y average interest coverage ratio for LLY stock is 22.95x.

DATE	INTEREST COVERAGE RATIO
2026-03-31	26.66x
2025-12-31	71.34x
2025-09-30	46.69x
2025-06-30	28.62x
2025-03-31	22.19x
2024-12-31	25.80x
2024-09-30	23.61x
2024-06-30	24.07x
2024-03-31	15.23x
2023-12-31	23.10x
2023-09-30	28.42x
2023-06-30	19.44x
2023-03-31	16.68x
2022-12-31	26.28x
2022-09-30	25.00x
2022-06-30	21.49x
2022-03-31	31.37x
2021-12-31	30.36x
2021-09-30	25.50x
2021-06-30	17.46x
2021-03-31	19.96x
2020-12-31	26.74x
2020-09-30	16.67x
2020-06-30	16.70x
2020-03-31	18.89x
2019-12-31	16.72x
2019-09-30	14.53x
2019-06-30	14.18x
2019-03-31	14.59x
2018-12-31	20.43x
2018-09-30	24.32x
2018-06-30	26.05x
2018-03-31	23.02x
2017-12-31	12.22x
2017-09-30	19.66x
2017-06-30	24.52x
2017-03-31	23.98x
2016-12-31	20.50x
2016-09-30	20.95x
2016-06-30	22.72x
2016-03-31	19.52x
2015-12-31	16.83x
2015-09-30	25.54x
2015-06-30	25.96x
2015-03-31	21.74x
2014-12-31	23.60x
2014-09-30	18.20x
2014-06-30	24.97x
2014-03-31	22.92x
2013-12-31	25.02x
2013-09-30	38.81x
2013-06-30	38.87x
2013-03-31	35.82x
2012-12-31	29.85x
2012-09-30	24.24x
2012-06-30	27.96x
2012-03-31	31.02x
2011-12-31	24.67x
2011-09-30	35.80x
2011-06-30	38.16x
2011-03-31	38.20x
2010-12-31	35.37x
2010-09-30	37.13x
2010-06-30	37.52x
2010-03-31	35.91x
2009-12-31	26.55x
2009-09-30	28.48x
2009-06-30	24.83x
2009-03-31	20.02x
2008-12-31	18.43x
2008-09-30	33.00x
2008-06-30	30.47x
2008-03-31	21.22x

DATE

INTEREST COVERAGE RATIO

2026-03-31

26.66x

2025-12-31

71.34x

2025-09-30

46.69x

2025-06-30

28.62x

2025-03-31

22.19x

2024-12-31

25.80x

2024-09-30

23.61x

2024-06-30

24.07x

2024-03-31

15.23x

2023-12-31

23.10x

2023-09-30

28.42x

2023-06-30

19.44x

2023-03-31

16.68x

2022-12-31

26.28x

2022-09-30

25.00x

2022-06-30

21.49x

2022-03-31

31.37x

2021-12-31

30.36x

2021-09-30

25.50x

2021-06-30

17.46x

2021-03-31

19.96x

2020-12-31

26.74x

2020-09-30

16.67x

2020-06-30

16.70x

2020-03-31

18.89x

2019-12-31

16.72x

2019-09-30

14.53x

2019-06-30

14.18x

2019-03-31

14.59x

2018-12-31

20.43x

2018-09-30

24.32x

2018-06-30

26.05x

2018-03-31

23.02x

2017-12-31

12.22x

2017-09-30

19.66x

2017-06-30

24.52x

2017-03-31

23.98x

2016-12-31

20.50x

2016-09-30

20.95x

2016-06-30

22.72x

2016-03-31

19.52x

2015-12-31

16.83x

2015-09-30

25.54x

2015-06-30

25.96x

2015-03-31

21.74x

2014-12-31

23.60x

2014-09-30

18.20x

2014-06-30

24.97x

2014-03-31

22.92x

2013-12-31

25.02x

2013-09-30

38.81x

2013-06-30

38.87x

2013-03-31

35.82x

2012-12-31

29.85x

2012-09-30

24.24x

2012-06-30

27.96x

2012-03-31

31.02x

2011-12-31

24.67x

2011-09-30

35.80x

2011-06-30

38.16x

2011-03-31

38.20x

2010-12-31

35.37x

2010-09-30

37.13x

2010-06-30

37.52x

2010-03-31

35.91x

2009-12-31

26.55x

2009-09-30

28.48x

2009-06-30

24.83x

2009-03-31

20.02x

2008-12-31

18.43x

2008-09-30

33.00x

2008-06-30

30.47x

2008-03-31

21.22x

Interest Coverage Ratio: 26.66x

LLY Interest Coverage Ratio

LLY Average Interest Coverage Ratio Chart

LLY Current vs Average Interest Coverage Ratio Chart

LLY Interest Coverage Ratio Metrics

LLY Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

LLY Interest Coverage Ratio History

Related Metrics